27.53 USD
+0.26
0.95%
At close Jul 11, 4:00 PM EDT
After hours
27.53
+0.00
0.00%
1 day
0.95%
5 days
1.51%
1 month
0.58%
3 months
11.73%
6 months
13.11%
Year to date
5.88%
1 year
-1.11%
5 years
-50.42%
10 years
-85.04%
 

About: Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Employees: 8,379

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

295% more call options, than puts

Call options by funds: $53.3M | Put options by funds: $13.5M

21% more repeat investments, than reductions

Existing positions increased: 137 | Existing positions reduced: 113

9% more funds holding in top 10

Funds holding in top 10: 11 [Q4 2024] → 12 (+1) [Q1 2025]

9% more capital invested

Capital invested by funds: $3.45B [Q4 2024] → $3.75B (+$306M) [Q1 2025]

0.1% less ownership

Funds ownership: 98.19% [Q4 2024] → 98.09% (-0.1%) [Q1 2025]

3% less funds holding

Funds holding: 353 [Q4 2024] → 342 (-11) [Q1 2025]

14% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 51

Research analyst outlook

We haven’t received any recent analyst ratings for PRGO.

Financial journalist opinion

Based on 5 articles about PRGO published over the past 30 days

Positive
Zacks Investment Research
2 days ago
Should Value Investors Buy Perrigo (PRGO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Perrigo (PRGO) Stock?
Neutral
PRNewsWire
1 week ago
Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance
Company to Scale and Optimize Global Category-Led, Market Activation Growth Model Roberto Khoury, EVP & President Consumer Self-Care International (CSCI), Appointed to New Position of EVP & Chief Commercial Officer to Lead Global Market Activation Triona Schmelter, EVP & President Consumer Self-Care Americas (CSCA), to Leave Organization DUBLIN , July 1, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that it is scaling and optimizing its proven growth model—anchored in global Category Leadership and Market Activation—across the organization to enhance agility, accelerate innovation, and drive long-term sustainable growth. This organizational alignment advances Perrigo's multi-year Stabilize, Streamline and Strengthen ('Three-S') plan and reflects operational readiness across the Company.
Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance
Neutral
PRNewsWire
1 week ago
Good Start® | Dr. Brown's™ Launches 30-Day "Gentle Baby Formula Giveaway Contest" with a Generous Donation to Baby2Baby
Beginning July 1, 2025, a month-long giveaway contest will award 100 winners with two months' worth of Good Start® | Dr. Brown's™ Gentle Pro™ baby formula plus Dr. Brown's products (valued at $516.49) – and support families in need with a donation of formula to Baby2Baby that exceeds the total contest value GRAND RAPIDS, Mich. , July 1, 2025 /PRNewswire/ -- Today, the makers of Good Start® | Dr. Brown's™ infant formula announced a nationwide giveaway contest to support families across the country.
Good Start® | Dr. Brown's™ Launches 30-Day "Gentle Baby Formula Giveaway Contest" with a Generous Donation to Baby2Baby
Positive
Zacks Investment Research
2 weeks ago
Should Value Investors Buy Perrigo (PRGO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Perrigo (PRGO) Stock?
Positive
MarketBeat
3 weeks ago
These 3 Dividend Stocks Combine Strong Yields With Upside
Dividend stocks can play many roles in an investor's portfolio. Income generation is paramount.
These 3 Dividend Stocks Combine Strong Yields With Upside
Positive
Zacks Investment Research
1 month ago
Does Perrigo (PRGO) Have the Potential to Rally 32.86% as Wall Street Analysts Expect?
The consensus price target hints at a 32.9% upside potential for Perrigo (PRGO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Does Perrigo (PRGO) Have the Potential to Rally 32.86% as Wall Street Analysts Expect?
Negative
Zacks Investment Research
1 month ago
Why Is Perrigo (PRGO) Down 3.1% Since Last Earnings Report?
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
Why Is Perrigo (PRGO) Down 3.1% Since Last Earnings Report?
Positive
Zacks Investment Research
1 month ago
Are Investors Undervaluing Perrigo (PRGO) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Perrigo (PRGO) Right Now?
Neutral
PRNewsWire
1 month ago
Perrigo Announces Global Operations and Supply Chain Leadership Transition
Ron Janish, EVP Global Operations and Supply Chain, to Retire Industry Veteran, Matt Winterman, Appointed EVP Product Supply, Operations Strategy & Transformation Officer DUBLIN , June 4, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Matt Winterman as Executive Vice President, Product Supply, Operations Strategy and Transformation Officer, effective June 23, 2025. Mr. Winterman succeeds Ron Janish, who will retire from the Company on September 30, 2025, following a distinguished career at Perrigo spanning more than two decades.
Perrigo Announces Global Operations and Supply Chain Leadership Transition
Neutral
PRNewsWire
1 month ago
Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
DUBLIN , May 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference, being conducted virtually on Tuesday, June 10 at 9 AM ET. Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.
Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
Charts implemented using Lightweight Charts™